Categories: Post

Large Hadron Collider is back in action!

On Easter Sunday beam began to circulate again in CERN’s Large Hadron Collider.  The world’s highest energy particle accelerator resumed operation after a two year shutdown to modify its magnets so it can collide protons at twice the former energy.  At half the energy, LHC “Run 1” discovered the Higgs boson; now scientists are excited to have a more powerful instrument to learn more about the Higgs boson and possibly see evidence of the Dark Matter in the universe (if it is due to a particle that can be produced in LHC proton collisions, of course).

The turning-on of the LHC is proceeding in carefully controlled steps to ensure the complex machine is behaving as intended.  There is good reason for this caution: at full energy and intensity, the LHC proton beam carries the same energy as an Airbus 380 in flight!  For the next week beams of protons will be permitted to orbit the 27 kilometer LHC racetrack at low energy so that precise orbit control measurements can be taken. Every so often part of the intense beam is allowed to smash into material near the detectors used to make the physics measurements. An example of this is shown in the picture. We call these “splash events” for obvious reasons. They are a useful tool for making sure the detector components are all live and functional.

By late April we hope to be recording the first collisions of protons at full energy and the search for new particles will begin.  The Chicago area hosts a large number of scientists working on the LHC machine or its experiments. Fermilab, Argonne, U Chicago, UI Chicago, UI Champagne, Northwestern, and NIU have large groups involved in the LHC experiments.

 

—Dr. Mark Oreglia is a Professor of Physics at the University of Chicago. He was a panelist on C2ST’s program, “Science + Cinema: New Screen Frontiers,” for his work on the film, “The Believers.”

c2st

Recent Posts

GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution

In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as…

8 hours ago

Vaccines: No Risk, No Reward

Vaccines are tools of modern medicine used in keeping us safe and healthy from the…

1 week ago

The Secret Psychology of Smiles

Did you know your smile is one of the most powerful social signals you have?…

2 weeks ago

The Curious Case of the CADs Effect: Is Time Travel Actually Real?

We’ve all heard of cause and effect, but what if our universe doesn’t actually follow…

1 month ago

Your Brain on ChatGPT: A Cognitive Neuroscientist’s Breakdown

Since the launch of ChatGPT in 2022, many people have wondered about the long-term impact…

1 month ago

Beyond Validation: Are Medical Devices Meeting Our Needs?

This past summer, I found myself teaching a classroom full of fourth through eighth graders.…

1 month ago